![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/g5-entertainment.jpg)
Transactions
Filter
![](https://www.carnegie.se/app/uploads/epi-files/Sweden/IB/Logotypes/g5-entertainment.jpg)
![](https://www.carnegie.se/app/uploads/epi-files/logos/hofsethbiocare.jpg)
Directed new share issue in Hofseth BioCare ASA (NO) — NOK 90 million
![](https://www.carnegie.se/app/uploads/epi-files/logos/byggmax.jpg)
Secondary placing of shares in Byggmax (SE) — SEK 638 million
![](https://www.carnegie.se/app/uploads/epi-files/logos/silkeborg-data.jpg)
Divestment of Silkeborg Data (DK) to Axcel (DK) by Jyske Bank (DK) — Amount not disclosed
![](https://www.carnegie.se/app/uploads/epi-files/logos/kjellcompany1.jpg)
Acquisition of Kjell & Company (SE) by FSN Capital (SE) — Amount not disclosed
![](https://www.carnegie.se/app/uploads/epi-files/logos/betsson.jpg)
Secondary placing of shares in Betsson (SE) — SEK 153 million
![](https://www.carnegie.se/app/uploads/epi-files/logos/peab.jpg)
Secondary placing of shares in Peab (SE) — SEK 186 million
![](https://www.carnegie.se/app/uploads/epi-files/logos/biotec-pharmacon.jpg)
Directed new share issue in Biotec Pharmacon ASA (NO) — NOK 78 million
![](https://www.carnegie.se/app/uploads/epi-files/logos/recipharm.jpg)
Initial public offering of Recipharm (SE) on NASDAQ OMX Stockholm — SEK 1.5 billion
Divestment of Phase One A/S (DK) to Silverfleet Capital (UK) — Amount not disclosed
![](https://www.carnegie.se/app/uploads/epi-files/logos/balder.jpg)
Secondary placing of of treasury shares in Fastighets AB Balder (SE) — SEK 221 million
![](https://www.carnegie.se/app/uploads/epi-files/logos/glo.jpg)